Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Fibroblasts are a dynamic cell type that achieve selective differentiated states to mediate acute wound healing and long-term tissue remodeling with scarring. With myocardial infarction injury, cardiomyocytes are replaced by secreted extracellular matrix proteins produced by proliferating and differentiating fibroblasts. Here, we employed 3 different mouse lineage-tracing models and stage-specific gene profiling to phenotypically analyze and classify resident cardiac fibroblast dynamics during myocardial infarction injury and stable scar formation. Fibroblasts were activated and highly proliferative, reaching a maximum rate within 2 to 4 days after infarction injury, at which point they expanded 3.5-fold and were maintained long term. By 3 to 7 days, these cells differentiated into myofibroblasts that secreted abundant extracellular matrix proteins and expressed smooth muscle α-actin to structurally support the necrotic area. By 7 to 10 days, myofibroblasts lost proliferative ability and smooth muscle α-actin expression as the collagen-containing extracellular matrix and scar fully matured. However, these same lineage-traced initial fibroblasts persisted within the scar, achieving a new molecular and stable differentiated state referred to as a matrifibrocyte, which was also observed in the scars of human hearts. These cells express common and unique extracellular matrix and tendon genes that are more specialized to support the mature scar.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and resemble POSTN-expressing matrifibrocytes7.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We used an Ang II/PE infusion model to study cardiac fibrosis which has inherent limitations3,4,7,39”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Computational lineage analysis predicted that FAP expression marks a fibroblast trajectory that transitions into populations including POSTN + matrifibrocytes 32 and myofibroblasts.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,406
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
Joe, A. W. B., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., & Rossi, F. M. V. (2010) · Nature Cell Biology · doi:10.1038/ncb2015 · Cited by 1,690
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A., & Kardon, G. (2011) · Development · doi:10.1242/dev.064162 · Cited by 1,249
Darby, I. A., Skalli, O., & Gabbiani, G. (1990) · PubMed · Cited by 1,189
Kajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 5×
“We previously showed that myofibroblasts in the heart can dedifferentiate and revert back to an “uninjured” state after a cardiac stress response resolves, such as with Ang II/PE agonist infusion and then its removal (23).”
BackgroundInfluentialSelf-citationBryant, S. J., & Anseth, K. S. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1217 · Cited by 845
Research works printed but not linked: 1
- 28. Ubil E, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature. 2014;514(7524):585–590. doi: 10.1038/nature13839. · DOI · Paper page
Cited by
Items 301–400 of 638
Tenkorang, M. A. A., Chalise, U., Daseke, M. J., Konfrst, S. R., & Lindsey, M. L. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190113 · Cited by 26
Krstevski, C., Cohen, C. D., Dona, M. S. I., & Pinto, A. R. (2020) · Biochemical Society Transactions · doi:10.1042/bst20191255 · Cited by 19
Komuro, J., Hashimoto, H., Katsuki, T., Kusumoto, D., Katoh, M., Ko, T., Ito, M., Katagiri, M., Kubota, M., Yamada, S., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00698-y · Cited by 24
“CFs are activated after MI and express many types of extracellular matrix proteins to stabilize scars 9 .”
Song, H., he, S. T., Li, S., Wu, J., Yin, W., Shao, Z., Du, G., Wu, J., Li, J., Weisel, R. D., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15597 · Cited by 16
Methatham, T., Nagai, R., & Aizawa, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084302 · Cited by 19
Hippo-Yap signaling in cardiac and fibrotic remodeling
Re, D. P. D. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100492 · Cited by 22
Song, J., Du, J., Tan, X. L., Li, Y., Yu, Q. C., Liu, W., Zhu, X., & Cong, B. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121973 · Cited by 16
Siamwala, J. H., Pagano, F. S., Dubielecka, P. M., Ivey, M. J., Guirao-Abad, J. P., Zhao, A., Chen, S. D., Granston, H., Jeong, J. Y., Rounds, S., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05463-0 · Cited by 22
Self-citationMouton, A. J., Flynn, E. R., Moak, S. P., Li, X., da Silva, A. A., Wang, Z., do Carmo, J. M., Hall, M. E., & Hall, J. E. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018212 · Cited by 17
The Future of Direct Cardiac Reprogramming: Any GMT Cocktail Variety?
López-Muneta, L., Miranda-Arrubla, J., & Carvajal‐Vergara, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217950 · Cited by 16
“Inflammation produces cardiac fibroblast activation and mobilization to the injury site, where different components of the extracellular matrix are secreted to repair the damage [63,64].”
BackgroundCardiac Cell Therapy Fails to Rejuvenate the Chronically Scarred Rodent Heart
Vagnozzi, R. J., Kasam, R. K., Sargent, M. A., & Molkentin, J. D. (2021) · Circulation · doi:10.1161/circulationaha.120.053080 · Cited by 16
Self-citationCardiac fibroblast sub-types in vitro reflect pathological cardiac remodeling in vivo
Herum, K. M., Weng, G., Kahnert, K., Waikel, R., Milburn, G., Conger, A., Anaya, P., Campbell, K. S., Lundby, A., Won, K. J., et al. (2022) · Matrix Biology Plus · doi:10.1016/j.mbplus.2022.100113 · Cited by 15
“To test these predictions, we took advantage of a bulk RNAseq data set of mouse hearts at different time points after myocardial infarction (MI), published earlier by the Molkentin group [14].”
BackgroundMethodUnderstanding the Mechanism of Cardiotoxicity Induced by Nanomaterials: A Comprehensive Review
Zheng, Z., Zhu, S., Wang, X., Wu, H., Fu, M., Hu, H., Gu, Z., & Zhang, C. (2025) · Small Science · doi:10.1002/smsc.202400498 · Cited by 22
Role of the Renin–Angiotensin–Aldosterone System in Dystrophin-Deficient Cardiomyopathy
Rodríguez‐González, M., Lubián-Gutiérrez, M., Cascales-Poyatos, H. M., Pérez-Reviriego, Á. A., & Castellano‐Martínez, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010356 · Cited by 14
Kibschull, M., Nguyen, T. T. N., Chow, T., Alarab, M., Lye, S. J., Rogers, I. M., & Shynlova, O. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-31780-9 · Cited by 15
Isolation of Adult Mouse Cardiac Fibroblasts
Almazloum, A., & Khalil, H. (2023) · Current Protocols · doi:10.1002/cpz1.840 · Cited by 18
Self-citationLai, Y., Chang, S., Tung, Y., Chang, G., Almeida, C. D., Chen, W.-J., Yeh, Y., & Tsai, F. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31248 · Cited by 19
“Cardiac fibroblasts can exist in many stages (Fu et al., 2018) (5 ng/mL), activin A (20 ng/mL) or Nodal (2 µg/mL) (Kumar et al., 2001) and subsequently analyzed the expression of EndMT marker proteins (Twist, SMA, and Collagen I) and Sema3A. hAEECs treated with TGF ‐ β , activin A and Nodal showed…”
BackgroundFibrin hydrogels promote scar formation and prevent therapeutic angiogenesis in the heart
Melly, L., Grosso, A., Pop, C. S., Chu, Y., Nollevaux, M., Schachtrup, C., Marsano, A., Maggio, N. D., Rondelet, B., & Banfi, A. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3118 · Cited by 15
“…the evolution of postinfarction scar formation, fibrin hydrogels were progressively invaded by PDGF-Rα + cardiac fibroblasts (Kanisicak et al., 2016) over the first 5 days, which subsequently converted to α-SMA + myofibroblasts (Fu et al., 2018) with a maximum frequency by 7 days after injection.”
BackgroundA new concept of fibroblast dynamics in post–myocardial infarction remodeling
Eschenhagen, T. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121079 · Cited by 17
Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
Amrute, J. M., Luo, X., Penna, V., Bredemeyer, A., Yamawaki, T., Heo, G. S., Shi, S., Koenig, A., Yang, S., Kadyrov, F., et al. (2022) · bioRxiv · doi:10.1101/2022.10.17.512579 · Cited by 14
Fu, P., Han, X., Lin, Q., Wang, N., Sun, F., Zhang, Y., Li, H., & Zhang, B. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038142 · Cited by 16
“18,19 In this study, to characterize FAPI uptake during the acute phase, myocardial FAPI positron emission tomography (PET)/computed tomography (CT) imaging was scheduled around day 7.”
Shi, S. Y., Luo, X., Yamawaki, T., Li, C.-M., Ason, B. L., & Furtado, M. B. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01517-z · Cited by 14
Development of direct cardiac reprogramming for clinical applications
Yamada, Y., Sadahiro, T., & Ieda, M. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.03.002 · Cited by 16
Li, S., Kong, F., Xu, X., Song, S., Wu, Y., & Tong, J. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3631 · Cited by 13
The fate and role of the pericytes in myocardial diseases
Frangogiannis, N. G. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14204 · Cited by 16
“78 Tight regulation of inflammatory and fibrogenic responses is critical for minimizing adverse re-modelling of the infarcted heart.”
The Myofibroblast Fate of Therapeutic Mesenchymal Stromal Cells: Regeneration, Repair, or Despair?
Younesi, F. S., & Hinz, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168712 · Cited by 17
“Myofibroblast contractile activity promotes wound closure of injured skin and organizes ECM into mechanically resistant scar tissue in other organs; the depletion of α -SMA or pharmaceutic inhibition disrupts the normal process of wound healing [200,201].”
BackgroundHarnessing the regenerative potential of interleukin11 to enhance heart repair
Shin, K., Rodriguez, A., Kim, C., Silaban, I. M., Xia, Y., Sun, J., Dong, C., Keleş, S., Wang, J., Cao, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54060-0 · Cited by 16
“ACTA2, smooth muscle alpha ( α ) − 2 actin, is used as a biomarker for the injury-induced myo fi broblasts in mammalian hearts 65,66 , raising a question of ACTA2 expression in response to il11a OE.”
Dynamics of fibroblast activation in the infarcted heart
Bras, A. L. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0025-9 · Cited by 14
Qi, Z., Wu, D., Li, M., Yan, Z., Yang, X., Ji, N., Wang, Y., & Zhang, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117761 · Cited by 15
Picchio, V., Bordin, A., Floris, E., Cozzolino, C., Dhori, X., Peruzzi, M., Frati, G., FALCO, E. D., Pagano, F., & Chimenti, I. (2022) · PubMed · Cited by 18
Preventing hypocontractility-induced fibroblast expansion alleviates dilated cardiomyopathy
Bretherton, R. C., Reichardt, I. M., Zabrecky, K. A., Nagle, A., Bailey, L. R. J., Bugg, D., Smolgovsky, S. A., Gifford, A. L., McMillen, T. S., Goldstein, A. J., et al. (2025) · Science · doi:10.1126/science.adv9157 · Cited by 17
The Role of the Pentose Phosphate Pathway in Cardiovascular Diseases
Chen, Z., Zhang, Y., Qian, C., & Xia, L. (2025) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-025-07788-w · Cited by 16
“MI is the leading cause of mortality among all CVDs. Intense inflammatory responses occur in the infarct area, triggering tissue healing and remodeling to form permanent scars [70, 71].”
Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair
Zhang, M., Qin, Y., Zhou, T., Liu, M., Tang, T. A., Xia, N., Nie, S., Lv, B., Zhu, Z., Jiao, J., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.076321 · Cited by 20
Rurik, J. G., & Epstein, J. A. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0171 · Cited by 13
“Proteins selectively expressed by activated fibro-blasts include fibroblast activation protein (FAP) and peri-ostin (Tillmanns et al. , 2015; Kanisicak et al. , 2016; Fu et al. , 2018).”
Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction
Moggio, A., Schunkert, H., Kessler, T., & Sager, H. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415814 · Cited by 15
“Myofibroblasts become quiescent, collagen filaments cross-link and the re-vascularization process ends [35,36] (Figure 2).”
BackgroundGarvin, A. M., & Katwa, L. C. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00224.2023 · Cited by 16
Hui, W., Song, T., Yu, L., & Chen, X. (2023) · Antioxidants · doi:10.3390/antiox13010042 · Cited by 14
“Two raw datasets (GSE111059 [32] and GSE28416 [33]) containing gene expression data for cardiac fibroblasts post-MI and mouse embryo fibroblast were downloaded from the Gene Expression Omnibus (GEO).”
MethodHuyan, Y., Chen, X., Chang, Y., Hua, X., Fan, X., Shan, D., Xu, Z., Tao, M., Zhang, H., Liu, S., et al. (2022) · International Heart Journal · doi:10.1536/ihj.23-302 · Cited by 15
Emerging Epigenetic Therapies for the Treatment of Cardiac Fibrosis
Garitano, N., Aguado‐Alvaro, L. P., & Pelacho, B. (2025) · Biomedicines · doi:10.3390/biomedicines13051170 · Cited by 16
“Additionally, myofibroblasts progressively lose their contractile properties and transition into matrifibro-cytes, a specialized fibroblast subset involved in ECM maintenance [23].”
Thomas, D., & Wu, J. C. (2025) · iScience · doi:10.1016/j.isci.2025.113003 · Cited by 16
“142,143 In case of a sterile inflammation, the mobilization of the immune cells is triggered by release of damage associated molecular patterns (DAMPS) that regulate pro-inflammatory cytokines and chemokines in the heart.”
Inhibition of CREB-CBP Signaling Improves Fibroblast Plasticity for Direct Cardiac Reprogramming
Bektik, E., Sun, Y., Dennis, A. T., Sakon, P., Yang, D., Deschênes, I., & Fu, J. (2021) · Cells · doi:10.3390/cells10071572 · Cited by 13
“Fibroblasts in the heart can be classified into four major cellular states: quiescent fibroblast, activated fibroblast, myofibroblast, and matrifibrocyte, each showing different plasticity with their special epigenetic inheritance [22,23].”
BackgroundHippo signaling in cardiac fibroblasts during development, tissue repair, and fibrosis
Tsai, C.-R., & Martin, J. F. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2022.02.010 · Cited by 15
Impact of circadian time of dosing on cardiomyocyte-autonomous effects of glucocorticoids
Wintzinger, M., Panta, M., Miz, K., Prabakaran, A. D., Durumutla, H. B., Sargent, M. A., Peek, C. B., Bass, J. T., Molkentin, J. D., & Quattrocelli, M. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101528 · Cited by 13
“Echocardiography was performed in mice under 2% isoflurane inhalation anesthesia and the measurements were performed using a Vevo 2100 instrument with 18e38 MHz transducer (VisualSonics) as previously described [54,56,57], using M and B-mode recordings for fractional shortening and stroke volume quantitation.”
MethodSelf-citationXu, Y., Wu, A., Chen, J., Song, X., Chen, M., & Liu, Q. (2022) · Mediators of Inflammation · doi:10.1155/2022/8939449 · Cited by 13
“Costaining with anti-LBH and anti-vimentin, as well as anti-LBH and anti-CTnT, helped us to distinguish CFs (vimentin/CTnT) and CMs (vimentin/CTnT), and CFs were observed to be scattered in the cardiac interstitium in the sham group (Figure 1(b1–b4)), which agreed with the cardiac distribution of resident CFs [3].”
BackgroundResultGałdyszyńska, M., Zwoliński, R., Piera, L., Szymański, J., Jaszewski, R., & Drobnik, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114289 · Cited by 13
Perveen, S., Vanni, R., Iacono, M. L., Rastaldo, R., & Giachino, C. (2023) · Cells · doi:10.3390/cells12081166 · Cited by 13
What’s in a name? On fibroblast phenotype and nomenclature
Nagalingam, R. S., Al‐Hattab, D. S., & Czubryt, M. P. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0555 · Cited by 14
“By approximately four weeks, the majority of periostinlabelled cells undergo apoptosis as evidenced in the presence of TUNEL-positive nuclei (Fu et al. 2018).”
BackgroundInfluentialMicroRNA miR-215-5p Regulates Doxorubicin-induced Cardiomyocyte Injury by Targeting ZEB2
Xiong, X., He, Q., Liu, J., Dai, R., Zhang, H., Cao, Z., Liao, Y., Liu, B., Zhou, Y., Chen, J., et al. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001110 · Cited by 15
Long Noncoding RNAs in Cardiac Development
Alexanian, M., & Ounzain, S. (2020) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037374 · Cited by 16
Cell type specificity of Hippo-YAP signaling in cardiac development and disease
Guan, J., & Re, D. P. D. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.08.003 · Cited by 13
Beà, A., Valero, J. G., Irazoki, A., Lana, C., López‐Lluch, G., Portero‐Otín, M., Perez-Galan, P., Inserte, J., Ruiz‐Meana, M., Zorzano, A., et al. (2021) · FEBS Journal · doi:10.1111/febs.16283 · Cited by 14
Li, C., & Wang, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.902677 · Cited by 18
“One previous study showed that fibroblasts became activated and then were induced to differentiate into myofibroblasts (Fu et al., 2018).”
BackgroundDing, S., Zhang, X., Qiu, H., Wo, J., Zhang, F., & Na, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.873264 · Cited by 14
“During both human and mouse heart ischemic injury, cardiac fibroblasts became activated (marked by POSTN) and transformed into myofibroblasts (FAP, MYH11) or fibrocytes (CHAD, COMP) (Tallquist and Molkentin 2017; Fu et al., 2018; Tucker et al., 2020).”
BackgroundMyofibroblast senescence promotes arrhythmogenic remodeling in the aged infarcted rabbit heart
Baggett, B., Murphy, K. R., Sengun, E., Mi, E., Cao, Y., Turan, N. N., Lu, Y., Schofield, L., Kim, T. Y., Kabakov, A. Y., et al. (2023) · eLife · doi:10.7554/elife.84088 · Cited by 13
“…the high degree of α SMA signal in young and aged rabbits at 1 and 2 weeks post-MI and the subsequent decrease in α SMA signal is consistent with genetic lineage tracing studies in mice which suggest that myofibroblasts remain present in the scar but lose α SMA expression ( Fu et al., 2018 ).”
BackgroundResultHuang, Q., Zhou, Z., Xu, L., Zhan, P., & Huang, G. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116563 · Cited by 16
Ma, J., Chen, Q., Lin, D., & Ma, S. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70526 · Cited by 14
“Matrifibrocytes located in the mature scarred regions of human or murine hearts demonstrate a lack of EdU uptake capacity and diminished expression of α-SMA [24].”
Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts
Stojanović, S. D., Fuchs, M., Fiedler, J., Xiao, K., Meinecke, A., Just, A., Pich, A., Thum, T., & Kunz, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114126 · Cited by 13
Sahu, S. P., Liu, Q., Prasad, A., Hasan, S. M. A., Liu, Q., Rodriguez, M. X. B., Mukhopadhyay, O., Burk, D. H., Francis, J., Mukhopadhyay, S., et al. (2020) · Biomedical Optics Express · doi:10.1364/boe.410347 · Cited by 13
Self-citationWound Healing-related Functions of the p160 Steroid Receptor Coactivator Family
Mullany, L. K., Lonard, D. M., & O’Malley, B. W. (2020) · Endocrinology · doi:10.1210/endocr/bqaa232 · Cited by 12
“MCB-613 promotion of COMP-positive matrifibrocyte-like fibroblasts is suggestive of scar remodeling and maintenance associated with improved structural integrity that can lead to lasting protection following injury (69, 77).”
BackgroundNassal, D. M., Patel, N., Unudurthi, S. D., Shaheen, R., Yu, J., Mohler, P. J., & Hund, T. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100893 · Cited by 13
“injection daily) for 1 week to induce MerCreCre expression under regulation of the periostin promoter (56, 57).”
BackgroundLu, Y., Wu, Q., Liao, J., Zhang, S., Lü, K., Yang, S., Wu, Y., Dong, Q., Yuan, J. T., Zhao, N., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2913 · Cited by 11
“Recent studies have detected a new subpopulation of fibroblasts appearing after heart injury called “matrifibrocyte” (48), characterized by the loss of proliferation ability and α-SMA expression as the collagen-containing ECM and scar fully matured.”
BackgroundInflammation‐induced left ventricular fibrosis is partially mediated by tumor necrosis factor‐α
Manilall, A., Mokotedi, L. P., Gunter, S., Roux, R. L., Fourie, S., Flanagan, C. A., & Millen, A. M. E. (2021) · Physiological Reports · doi:10.14814/phy2.15062 · Cited by 15
Hippo-deficient cardiac fibroblasts differentiate into osteochondroprogenitorsPreprint
Tsai, C.-R., Kim, J. K., Li, X., Czarnewski, P., Li, G., Meng, F., Zheng, M., Zhao, X., Steimle, J. D., Grisanti, F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.06.556593 · Cited by 12
Aguado‐Alvaro, L. P., Garitano, N., Esser‐Skala, W., Sayers, J. R., del Valle, C., Alameda, D., Mendieta-Esteban, J., Calleja-Cervantes, M. E., Goñi‐Salaverri, A., Zazpe, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66597-9 · Cited by 15
“Downregulation of PDGFR α has been linked to fi brotic progression in different cardiac pathologies 6,8,10,12,29 , thus,wechosePDGFR α asaFACS-readoutof fi brotictransformationin our CRISPR screen.”
Bengel, F. M., Hess, A., Diekmann, J., & Thackeray, J. T. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01242-y · Cited by 16
Disease- and sex-specific differences in patients with heart valve disease: a proteome study
Nordmeyer, S., Kraus, M., Ziehm, M., Kirchner, M., Schafstedde, M., Kelm, M., Niquet, S., Stephen, M. M., Baczkó, I., Knosalla, C., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202201411 · Cited by 11
“Thrombospondin-5 ( COMP ) is also speci fi cally up-regulated in AS and may belong to the expression signature of matri fi brocytes, which are derived from POSTN - expressing cells and have been shown to form stiff scar tissue in infarcted mouse hearts (Fu et al, 2018).”
BackgroundProgranulin deficiency exacerbates cardiac remodeling after myocardial infarction
Sasaki, T., Kuse, Y., Nakamura, S., Shimazawa, M., & Hara, H. (2023) · FASEB BioAdvances · doi:10.1096/fba.2023-00084 · Cited by 10
“39 Considering these findings, PGRN could inhibit fibroblast activation, but not significantly affect early activation of fibroblasts following MI. PGRN treatment reduced Angiotensin II (Ang II)- induced cardiomyocyte hypertrophy.”
Cardiac Fibroblasts: Helping or Hurting
Shameem, M., Olson, S. L., de Velasco, E. M. F., Kumar, A., & Singh, B. N. (2025) · Genes · doi:10.3390/genes16040381 · Cited by 16
McCaffrey, S. L., Lim, G., Bullock, M., Kasparian, A. O., Clifton-Bligh, R. J., Campbell, W. B., Widiapradja, A., & Levick, S. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249757 · Cited by 13
“It has recently been shown that fibroblasts residing in the infarct scar at chronic time points assume an intermediate phenotype coined the “matrifibrocyte” that is not a quiescent fibroblast but has lost the proliferative and α-smooth muscle actin characteristics typical of myofibroblasts [21].”
BackgroundMyofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomes
Flinn, M. A., Alvarez‐Argote, S., Knas, M. C., Almeida, V. A., Paddock, S. J., Zhou, X., Buddell, T., Jamal, A., Taylor, R., Liu, P., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1142612 · Cited by 15
Advanced In Vitro Modeling to Study the Paradox of Mechanically Induced Cardiac Fibrosis
Gartner, T. C. L. B., Stein, J. M., Muylaert, D. E. P., Bouten, C. V. C., Doevendans, P. A., Khademhosseini, A., Suyker, W. J. L., Sluijter, J. P. G., & Hjortnaes, J. (2021) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2020.0298 · Cited by 13
“18 Recent studies have shown that quiescent fibroblasts are activated upon injury and a majority of those activated fi-broblasts will express a -SMA temporarily.”
Manipulating Cardiomyocyte Plasticity for Heart Regeneration
Ko, T., & Nomura, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.929256 · Cited by 13
YAP-Induced Glycolysis Drives Fibroinflammation and Disrupts Fibroblast Fidelity
Tsai, C.-R., Liu, L., Zhao, Y., Kim, J. H., Czarnewski, P., Li, G., Meng, F., Zheng, M., Steimle, J. D., Zhao, X., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326480 · Cited by 16
Gonzalez, B. A., Harmeyer, S. W., Song, T., Sadayappan, S., & Yutzey, K. E. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.01.001 · Cited by 10
Single-cell transcriptomes in the heart: when every epigenome counts
Gromova, T., Gehred, N., & Vondriska, T. M. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac040 · Cited by 12
Transcriptional regulation of cardiac fibroblast phenotypic plasticity
Villar, K. N. B., Liu, X., & Small, E. M. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100556 · Cited by 12
A mathematical model of immunomodulatory treatment in myocardial infarction
Moise, N., & Friedman, A. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111122 · Cited by 11
Aguado-Alvaro, L. P., Garitano, N., Abizanda, G., Larequi, E., Prósper, F., & Pelacho, B. (2022) · Biomedicines · doi:10.3390/biomedicines10102350 · Cited by 9
“As a limitation, the ability of this line to regulate gene expression in CFs has been shown to dramatically decrease after differentiation toward myofibroblasts [6].”
BackgroundLiu, Q., Li, C., Deng, B., Gao, P., Wang, L., Li, Y., Shiri, M., Alkaifi, F., Zhao, J., Stephens, J. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112166 · Cited by 16
Self-citationChi, J., Wu, N., Li, P., Hu, J., Cai, H., Lin, C., Lai, Y., Yang, H., Huang, J., Li, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-55804-0 · Cited by 10
“In addition, Cxs, one of the less well-studied pathways, can also lead to fibrosis 41 .”
BackgroundAvolio, E., Bassani, B., Campanile, M., Mohammed, K. A. K., Muti, P. C., Bruno, A., Spinetti, G., & Madeddu, P. R. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100033 · Cited by 9
Kwiecień, E., Kot, M., Czyz, L., Drabik, L., Mazurek, A., Sikorska, M., Skubera, M., Tekieli, Ł. M., Majka, M., & Musiałek, P. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x372908250117092252 · Cited by 9
“Fibroblasts interact with cardiomyocytes through several mechanisms [179].”
InfluentialA secretome atlas of cardiac fibroblasts from healthy and infarcted mouse hearts
Bahr, J., Poschmann, G., Jungmann, A., Busch, M., Ding, Z., Vogt, J., Zalfen, R., Steinhausen, J., Martínez, A. A. E., Wachtmeister, T., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08083-y · Cited by 11
“Togetherthese fi ndingsareinlinewiththenotionthat CFareaverydynamiccelltypethatachievesselectivedifferentiatedstatesintheprocessfromacutewoundhealingtolong-termremodeling 30 .”
Pathology of the Coronary Arteries and Myocardium in Kawasaki Disease
Shimizu, C., Pomares, J. M. P., Loy, C., Vlaminck, I. D., Tremoulet, A. H., Ruiz‐Villalba, A., & Burns, J. C. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-111523-023453 · Cited by 11
Altered Expression of ORAI and STIM Isoforms in Activated Human Cardiac Fibroblasts
Čendula, R., Chomaničová, N., Adamičková, A., Gažová, A., Kyselovič, J., & Máťuš, M. (2021) · Physiological Research · doi:10.33549/physiolres.934771 · Cited by 9
State of change: epigenetic and mitochondrial regulation of cardiac fibroblast activation
Garvin, A. M., & Hale, T. M. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100557 · Cited by 9
Multilineage contribution of CD34+ cells in cardiac remodeling after ischemia/reperfusion injury
Xie, J., Jiang, L., Wang, J., Yin, Y., Wang, R., Du, L., Chen, T., Ni, Z., Qiao, S., Gong, H., et al. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-00981-8 · Cited by 15
“This study showed that the percentage of M-Act kept increasing until 14 days after the cardiac injury, but the myomesenchymal cells normally faded within 2 weeks [8].”
BackgroundResultZhao, Z., Xu, H. H., Li, A., Pu, H., She, P., Li, G., & Wang, Y. (2024) · Composites Part B Engineering · doi:10.1016/j.compositesb.2024.111430 · Cited by 9
Therapeutic Use of Bioengineered Materials for Myocardial Infarction
Sedláková, V., Ruel, M., & Suuronen, E. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-31261-9_9 · Cited by 9
Lobb, D. C., Doviak, H., Brower, G. L., Romito, E., O’Neill, J. W., Smith, S. H., Shuman, J. A., Freels, P. D., Zellars, K. N., Freeburg, L., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000047 · Cited by 11
“A potentially important event is changes in fibroblast phenotype post-MI (Zamilpa et al., 2011; Ma et al., 2013, 2017; Shinde and Frangogiannis, 2014; Khalil et al., 2017; Fu et al., 2018; Wang et al., 2020).”
BackgroundEsmaeili, H., Li, C., Fu, X., & Jung, J. P. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.611936 · Cited by 9
“Specific ligands that only allow engagement with CMs are needed to avoid adverse activation of the expansion of cFBs and their differentiation into myofibroblasts (specifically associated with fibrosis) (Fu et al., 2018).”
BackgroundSelf-citationValls-Lacalle, L., Puertas-Umbert, L., Varona, S., Martínez‐González, J., Rodrı́guez, C., & Rodríguez‐Sinovas, A. (2021) · Antioxidants · doi:10.3390/antiox11010075 · Cited by 9
“Accordingly, it has been reported that myocardial infarction induced by permanent LAD ligation in mice up-regulates fibroblast LOX expression reaching a peak that coincides with the minimal proliferative activity of these cells [35].”
BackgroundNovel Techniques Targeting Fibroblasts after Ischemic Heart Injury
Cakir, S. N., Whitehead, K. M., Hendricks, H. K. L., & Brás, L. E. D. C. (2022) · Cells · doi:10.3390/cells11030402 · Cited by 10
“This tool coupled with visualization of BrdU or αSMA allowed to identify respectively proliferating fibroblasts within the post-MI scar area and determine whether these cells were adopting a myoFB phenotype [50].”
BackgroundMethodAbdeltawab, H., Khalifa, F., Hammouda, K., Miller, J. M., Meki, M. H., Ou, Q., El-Baz, A. S., & Mohamed, T. (2021) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-021-00571-6 · Cited by 9
Owenier, C., Hesse, J., Alter, C., Ding, Z., Marzoq, A. J., Petzsch, P., Köhrer, K., & Schrader, J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz193 · Cited by 9
Tan, X., Wang, X., Xu, S., Zeng, Y., Zhang, G., Xu, A., Jiang, Y., Jiang, H., Song, Y., Fan, J., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s495784 · Cited by 8
“43 Vascular smooth muscle cells (VSMCs) switch from a contractile phenotype to a synthetic phenotype, promoting vascular remodeling and the development of atherosclerosis.”
Yang, S., Pei, L., Huang, Z., Zhong, Y., Li, J., Hong, Y., Long, H., Chen, X., Zhou, C., Zheng, G., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00856-1 · Cited by 11
“However, the process of fibrotic remodeling increases ventricular stiffness, reduces ventricular compliance, and impairs both the systolic and diastolic functions of the heart (Fu et al. 2018; Frangogiannis 2019).”
BackgroundMcClendon, L. K., Lanz, R. B., Panigrahi, A., Gomez, K., Bolt, M. J., Liu, M., Stossi, F., Mancini, M. A., Dacso, C. C., Lonard, D. M., et al. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.07.001 · Cited by 9
Cellular Interactions of Cardiac Repair After Myocardial Infarction
Lindsey, M. L., Oliver, A. F., Gaye, A., Nde, P. N., DeLeon‐Pennell, K. Y., & Gonzalez, G. E. (2025) · Cells · doi:10.3390/cells14231903 · Cited by 14
“We now know that fibroblast activation is more complex than originally thought, with fibroblasts transitioning from pro-inflammatory cells at day 1 MI to anti-inflammatory cells that promote activation of endothelial cells at day 3 MI to scar-forming cells by day 7 MI [23,53].”
Baddour, T., Ninh, V. K., Gorashi, R. M., Peña, R., King, K. R., & Aguado, B. A. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.324694 · Cited by 9
Metadata
- Authors
- Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., & Molkentin, J. D.
- Affiliations
- Louisiana State University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-04-16
- Volume
- 128
- Issue
- 5
- Pages
- 2127-2143
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5957472
- OpenAlex
- W2800350399
- Cited by
- 636
- References
- 54
- Citations by year
- 2026: 58 · 2025: 81 · 2024: 71 · 2023: 93 · 2022: 87 · 2021: 86 · 2020: 90 · 2019: 52 · 2018: 17
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institutes of Health (R01 HL142217)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Keywords
- cardiac fibroblasts, myocardial infarction, scar formation, myofibroblasts, fibroblast differentiation, lineage tracing, extracellular matrix, smooth muscle actin, collagen, cardiac remodeling, wound healing
- MeSH terms
- Animals, Cell Differentiation, Cicatrix, Extracellular Matrix, Female, Humans, Male, Myocardial Infarction, Myocardium, Extracellular Matrix Proteins, Myoblasts, Cardiac, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.